(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione,
1356, BI,
1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-,
BI 1356,
BI-1356,
BI1356,
Linagliptin,
Tradjenta,
Trajenta,
Linagliptin,
668270-12-0,
Tradjenta,
Ondero,
BI 1356,
BI-1356,
Linagliptin (BI-1356),
Trajenta,
UNII-3X29ZEJ4R2,
BI-1356-BS,
3X29ZEJ4R2,
CHEMBL237500,
CHEBI:68610,
8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione,
(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione,
8-[(3r)-3-Aminopiperidin-1-Yl]-7-But-2-Yn-1-Yl-3-Methyl-1-[(4-Methylquinazolin-2-Yl)methyl]-3,7-Dihydro-1h-Purine-2,6-Dione,
Linagliptin S-Isomer,
(R)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione,
8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione,
8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione,
Trazenta,
Linagliptin [USAN:INN:JAN],
HSDB 8204,
Tradjenta (TN),
(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione,
linagliptin-bi-1356,
MLS006010217,
SCHEMBL160188,
Linagliptin (JAN/USAN/INN),
GTPL6318,
BI 1356BS,
EX-A076,
LTXREWYXXSTFRX-QGZVFWFLSA-N,
BCPP000185,
BS 1356 BS,
BS-1356-BS,
C25H28N8O2,
BCP02462,
ZINC3820029,
BDBM50228403,
GP5216,
MFCD14635356,
s3031,
AKOS015951179,
AKOS015995251,
AC-8761,
ACN-028592,
AN-2539,
API0007204,
BCP9000854,
CS-0637,
DB08882,
RL04547,
NCGC00346655-01,
1H-Purine-2,6-dione, 8-((3R)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-,
1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-,
8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione,
AJ-45731,
AS-35080,
HY-10284,
SC-66358,
SC-83230,
SMR004701306,
AB0008009,
AB1008521,
AX8161416,
FT-0670793,
SW219813-1,
X1062,
KS-00000765,
D09566,
Q-4491,
AB01563307_01,
AB01563307_03,
270L120,
J-519354,
(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione,
1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-aminopiperidin-1-yl)xanthine,
1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)aminopiperidin-1-yl)xanthine,
1-[(4-methyl-quinazolin-2yl) methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R) amino-piperidin-1-yl]-xanthine,
1-[(4-Methylquinazolin-2-yl)-methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-aminopiperidin-1-yl)-xanthine,
1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-aminopiperidin-1-yl)-xanthine,
8-[(3R)-3-amino-1-piperidyl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione,
Ondero (TN),
Linagliptin [USAN:INN],
D02EYG,
cc-405,
BI1356,
CS-O-30970,
CID10096344,
1356, BI,
CID 10096344,
A4034,
C568794,
D000069476,
668270-11-9,
8-[3(R)-aminopiperidin-1-yl]-7-(2-butynyl)-3-methyl-1-(4-methylquinazolin-2-ylmethyl)xanthine,